Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 ...

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help people with diabetes manage ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

Food and Drug Administration Commissioner Marty Makary said the agency ... panel alarms pediatricians with inquiries into ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...